DM
COGT icon

Deerfield Management’s Cogent Biosciences COGT Stock Holding History

Deerfield Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194M Sell
5,006,104
-4,037,799
-45% -$141M 2.02% 11
2026
Q1 		$348M Hold
9,043,903
– – 4.11% 3
2025
Q4 		$321M Sell
9,043,903
-9,215
-0.1% -$259K 4.1% 3
2025
Q3 		$130M Buy
9,053,118
+6,412,903
+243% +$76M 1.98% 10
2025
Q2 		$19M Buy
2,640,215
+6,353
+0.2% +$35.2K 0.34% 49
2025
Q1 		$15.8M Buy
2,633,862
+2,862
+0.1% +$22.4K 0.31% 56
2024
Q4 		$20.5M Sell
2,631,000
-1,113,263
-30% -$11.1M 0.39% 51
2024
Q3 		$40.4M Hold
3,744,263
– – 0.6% 35
2024
Q2 		$31.6M Buy
3,744,263
+2,209,918
+144% +$16.8M 0.53% 41
2024
Q1 		$10.3M Buy
1,534,345
+445,000
+41% +$2.75M 0.18% 65
2023
Q4 		$6.41M Hold
1,089,345
– – 0.12% 58
2023
Q3 		$10.6M Sell
1,089,345
-2,277,000
-68% -$27M 0.23% 55
2023
Q2 		$39.9M Buy
3,366,345
+400,000
+13% +$4.59M 0.85% 32
2023
Q1 		$32M Hold
2,966,345
– – 0.71% 39
2022
Q4 		$34.3M Hold
2,966,345
– – 0.71% 43
2022
Q3 		$44.3M Sell
2,966,345
-2,910,460
-50% -$39.9M 0.88% 37
2022
Q2 		$53M Buy
5,876,805
+4,275,805
+267% +$29.2M 1.09% 31
2022
Q1 		$12M Hold
1,601,000
– – 0.27% 66
2021
Q4 		$13.7M Hold
1,601,000
– – 0.29% 74
2021
Q3 		$13.5M Hold
1,601,000
– – 0.26% 84
2021
Q2 		$13M Buy
1,601,000
+601,000
+60% +$5.08M 0.23% 102
2021
Q1 		$8.78M Hold
1,000,000
– – 0.18% 107
2020
Q4 		$11.2M Buy
+1,000,000
New +$11M 0.22% 97

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deerfield Management's COGT Position: Q2 2026 in Review

Deerfield Management reduced its Cogent Biosciences (COGT) stake by 45% in Q2 2026, selling an estimated $141M and leaving 5,006,104 shares worth $194M. The position accounts for 2.02% of the portfolio, ranked #11.

Deerfield Management first reported a position in COGT in Q4 2020 and has held it in 23 quarters since. The position peaked at $348M in Q1 2026. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Deerfield Management held 5,006,104 shares of Cogent Biosciences worth $194M as of Q2 2026.
  • Deerfield Management sold 4,037,799 Cogent Biosciences shares in Q2 2026, an estimated $141M.
  • Cogent Biosciences made up 2.02% of Deerfield Management's portfolio in Q2 2026, its #11 holding.
  • Deerfield Management first reported a position in Cogent Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Deerfield Management's Cogent Biosciences position peaked at $348M in Q1 2026.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.